China ‘harvesting’ Falun Gong organs: report

Members of the Falun Gong group act out a scene of forced organ harvesting. (File/AFP)
Updated 18 June 2019

China ‘harvesting’ Falun Gong organs: report

  • The panel said a considerable amount of people were affected by the forced organ collection
  • The report said the waiting time for organ transplants is considerably short

LONDON: Forced organ harvesting has been carried out “for years throughout China” and members of the Falun Gong spiritual group have “probably” been the main victims, according to a panel of lawyers.
A report by the London-based China Tribunal, released to journalists ahead of a summary to be published online on Wednesday, concluded that “forced organ harvesting continues till today.”
The panel said it was “unanimously, and sure beyond reasonable doubt — that in China forced organ harvesting from prisoners of conscience has been practiced for a substantial period of time involving a very substantial number of victims.”
“Falun Gong practitioners have been one — and probably the main — source of organ supply,” it added.
The China Tribunal was set up by campaign group the “International Coalition to End Transplant Abuse in China” to examine the issue.
The panel, headed by British lawyer Geoffrey Nice, warned that the “concerted persecution and medical testing” of China’s Muslim Uighurs meant “evidence of forced organ harvesting of this group may emerge in due course.”
The report cited “extraordinarily short waiting times” for organs and the number of transplant operations performed as evidence, highlighting the “impossibility of there being anything like sufficient ‘eligible donors’.”
China has repeatedly denied accusations that it takes organs from prisoners of conscience.
A government spokesman issued a statement before the report’s release saying “we hope that the British people will not be misled by rumors.”


Russia says India to produce 100 million doses of Sputnik vaccine

Updated 27 November 2020

Russia says India to produce 100 million doses of Sputnik vaccine

  • Hetero, one of India’s leading generic pharmaceutical companies, have agreed to produce in India over 100 million doses per year

MOSCOW: The Russian Direct Investment Fund (RDIF), one of the developers of Russia’s Sputnik V coronavirus vaccine, announced Friday that India-based drugmaker Hetero will produce over 100 million doses of the jab.
“Hetero, one of India’s leading generic pharmaceutical companies, have agreed to produce in India over 100 million doses per year of the world’s first registered vaccine against the novel coronavirus infection — Sputnik V,” the RDIF said in a statement, adding that production was expected to start in early 2021.